Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 3 12Phase 1/2 7Phase 1 5Phase EARLY_PHASE1 1

Status

Recruiting 3Active not recruiting 2

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Other solid neoplasm 1Breast 1

Conditions

Neoplasm Metastasis 2Urinary Bladder Neoplasms 1Lung Neoplasms 1Localized Muscle Invasive Bladder Urothelial Carcinoma 1Liver Failure 1Breast Neoplasms 1Advanced Solid Tumors 1

Interventions

Specimen Handling 150pembrolizumab 132Magnetic Resonance Spectroscopy 120Cyclophosphamide 118Biopsy 106fludarabine 90Nivolumab 61Carboplatin 55Radiotherapy 49Cisplatin 49Gemcitabine 48venetoclax 43Paclitaxel 43Cetuximab 40fludarabine phosphate 39Ipilimumab 36Fluorouracil 35atezolizumab 34Bevacizumab 33durvalumab 30Radiation 30Oxaliplatin 29X-Rays 28Leucovorin 28Dexamethasone 28Azacitidine 27Irinotecan 26Cytarabine 26Radiosurgery 24Injections 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × sacituzumab govitecan × 90 days × Clear all
NCT04617522 2026-06-02

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

Gilead Sciences

Phase 1 Recruiting
30 enrolled

Neoplasm Metastasis, Liver Failure

NCT06167317 2026-05-28

Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

Gilead Sciences

Phase 1 Recruiting
278 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT05143229 2026-05-01

ASSET

University of Kansas Medical Center

Phase 1 Active not recruiting
18 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04794699 2026-04-09

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

IDEAYA Biosciences

Phase 1 Active not recruiting
169 enrolled
GenitourinaryThoracic

Urinary Bladder Neoplasms, Lung Neoplasms

NCT05833867 2026-03-13

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

Case Comprehensive Cancer Center

Phase 1 Recruiting
20 enrolled
Genitourinary

Localized Muscle Invasive Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡